A single centre, placebo controlled trial to investigate the safety and tolerability of bisoprolol in patients with chronic heart failure and chronic obstructive pulmonary disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN20367656

Enrollment

Registered

2003-09-12

Start date

2003-05-17

Completion date

Unknown

Last updated

2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Heart failure Circulatory System Heart failure

Interventions

Randomised controlled trial.

Eligibility

Inclusion criteria

Inclusion criteria: Total number of subjects = 20.

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
1. a significant deterioration in spirometry (forced expiratory volume in one second [FEV1]) measurements 2. the levels of several neurohormones in heart failure patient's blood	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026